Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.
Am J Chin Med. 2012;40(6):1307-19. doi: 10.1142/S0192415X12500966.
The injury of endothelial cell is the critical event of vascular disease. In endothelial cell, oxidative stress is regarded as critical to pathogenic factors in endothelial cell injury and apoptosis. Tanshinone IIA is the main effective component of Salvia miltiorrhiza known as "Danshen" in traditional Chinese medicine for treating cardiovascular disorders, but the mechanism by which it exerts the protective effect is not well established. The present study was designed to test the hypothesis that tanshinone IIA can inhibit hydrogen peroxide ( H(2)O(2) )-induced injury and unravel its intracellular mechanism in human umbilical vein endothelial cells (HUVECs). In this study, HUVECs were treated with tanshinone IIA in the presence/absence of H(2)O(2) . The protective effects of tanshinone IIA against H(2)O(2) were evaluated. Our results show that HUVECs incubated with 200 μM H(2)O(2) had significantly decreased the viability of endothelial cells, which was accompanied with apparent cell apoptosis, the activation of caspase-3 and the upregulation of p53 expression, which was known to play a key role in H(2)O(2) -induced cell apoptosis. However, pretreatment with tanshinone IIA (3-10 μM) resulted in a significant resistance to H(2)O(2) -induced apoptosis. In addition, pretreatment with tanshinone IIA decreased the activity of caspase-3 and p53 expression. Tanshinone IIA also induced activating transcription factor (ATF) 3 expression; while knockdown of ATF-3 with ATF-3 siRNAsignificantly reduced tanshinone IIA's protective effect. In conclusion, the present study shows that tanshinone IIA can protect endothelial cells against oxidative injury induced by H(2)O(2) , suggesting that this compound may constitute a promising intervention against cardiovascular disorders and ATF-3 may play an important role in this process.
内皮细胞损伤是血管疾病的关键事件。在内皮细胞中,氧化应激被认为是内皮细胞损伤和凋亡的致病因素中的关键因素。丹参酮 IIA 是丹参(丹参)这一传统中药治疗心血管疾病的主要有效成分,但它发挥保护作用的机制尚未得到很好的确定。本研究旨在验证丹参酮 IIA 可抑制过氧化氢(H2O2)诱导的损伤,并阐明其在人脐静脉内皮细胞(HUVEC)中的细胞内机制的假说。在这项研究中,用 H2O2 处理 HUVEC 并加入/不加入丹参酮 IIA。评估丹参酮 IIA 对 H2O2 的保护作用。我们的结果表明,用 200μM H2O2 孵育的 HUVEC 显著降低了内皮细胞的活力,伴随着明显的细胞凋亡,caspase-3 的激活和 p53 表达的上调,这在 H2O2 诱导的细胞凋亡中起着关键作用。然而,用丹参酮 IIA(3-10μM)预处理可显著抵抗 H2O2 诱导的细胞凋亡。此外,丹参酮 IIA 预处理降低了 caspase-3 的活性和 p53 的表达。丹参酮 IIA 还诱导激活转录因子(ATF)3 的表达;而用 ATF-3 siRNA 敲低 ATF-3 则显著降低了丹参酮 IIA 的保护作用。综上所述,本研究表明丹参酮 IIA 可保护内皮细胞免受 H2O2 诱导的氧化损伤,提示该化合物可能成为治疗心血管疾病的有前途的干预措施,而 ATF-3 可能在此过程中发挥重要作用。